Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis

Virus Research

Volumn 194, Issue , 2014, Pages 145-158

  Desforges, Marc ^a   Le Coupanec, Alain ^a   Stodola, Jenny K ^a   Meessen Pinard, Mathieu ^a   Talbot, Pierre J ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

CNS infection; Human coronavirus; Neuroinvasion; Neurological diseases; Respiratory viral infection

Indexed keywords

CYCLOSPORIN A; STRUCTURAL PROTEIN;

ASTHMA; AUTOIMMUNITY; BASIC RESEARCH; BLOOD BRAIN BARRIER; CELL DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CORONAVIRUS INFECTION; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENCEPHALITIS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFLUENZA VIRUS C; LIFE CYCLE; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTROPISM; NONHUMAN; PATHOGENESIS; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; TARGET CELL; VIRUS CELL INTERACTION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; COMPLICATION; CORONAVIRIDAE; HOST PATHOGEN INTERACTION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; VIROLOGY;

CORONAVIRUS;

CENTRAL NERVOUS SYSTEM INFECTIONS; CORONAVIRUS; CORONAVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 84920600729     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.09.011     Document Type: Review

References (200)

1. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129(2):154-169.
2. Arbour N., Cote G., Lachance C., Tardieu M., Cashman N.R., Talbot P.J. Acute and persistent infection of human neural cell lines by human coronavirus OC43. J. Virol. 1999, 73(4):3338-3350.
3. Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000, 74(19):8913-8921.
4. Arbour N., Ekande S., Cote G., Lachance C., Chagnon F., Tardieu M., Cashman N.R., Talbot P.J. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J. Virol. 1999, 73(4):3326-3337.
5. Argyris E.G., Acheampong E., Wang F., Huang J., Chen K., Mukhtar M., Zhang H. The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. Virology 2007, 367(2):440-451.
6. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A., Al-Rabiah F.A., Al-Hajjar S., Al-Barrak A., Flemban H., Al-Nassir W.N., Balkhy H.H., Al-Hakeem R.F., Makhdoom H.Q., Zumla A.I., Memish Z.A. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013, 13(9):752-761.
7. Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., Alabdullatif Z.N., Assad M., Almulhim A., Makhdoom H., Madani H., Alhakeem R., Al-Tawfiq J.A., Cotten M., Watson S.J., Kellam P., Zumla A.I., Memish Z.A. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 2013, 369(5):407-416.
8. Aurelian L. HSV-induced apoptosis in herpes encephalitis. Curr. Top. Microbiol. Immunol. 2005, 289:79-111.
9. Barnett E.M., Perlman S. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 1993, 194(1):185-191.
10. Bender S.J., Weiss S.R. Pathogenesis of murine coronavirus in the central nervous system. J. Neuroimmune Pharmacol.: Off. J. Soc. Neuroimmune Pharmacol. 2010, 5(3):336-354.
11. Bentz G.L., Jarquin-Pardo M., Chan G., Smith M.S., Sinzger C., Yurochko A.D. Human cytomegalovirus (HCMV) infection of endothelial cells promotes naive monocyte extravasation and transfer of productive virus to enhance hematogenous dissemination of HCMV. J. Virol. 2006, 80(23):11539-11555.
12. Beraki S., Aronsson F., Karlsson H., Ogren S.O., Kristensson K. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol. Psychiatry 2005, 10(3):299-308.
13. Berth S.H., Leopold P.L., Morfini G.N. Virus-induced neuronal dysfunction and degeneration. Front. Biosci. 2009, 14:5239-5259.
14. Big C., Reineck L.A., Aronoff D.M. Viral infections of the central nervous system: a case-based review. Clin. Med. Res. 2009, 7(4):142-146.
15. Bonavia A., Arbour N., Yong V.W., Talbot P.J. Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J. Virol. 1997, 71(1):800-806.
16. Boucher A., Desforges M., Duquette P., Talbot P.J. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin. Immunol. 2007, 123(3):258-267.
17. Bove R., Chitnis T. Sexual disparities in the incidence and course of MS. Clin. Immunol. 2013, 149(2):201-210.
18. Braden C.R., Dowell S.F., Jernigan D.B., Hughes J.M. Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome. Emerg. Infect. Dis. 2013, 19(6):864-869.
19. Brian D.A., Baric R.S. Coronavirus genome structure and replication. Curr. Top. Microbiol. Immunol. 2005, 287:1-30.
20. Brison E., Jacomy H., Desforges M., Talbot P.J. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein. J. Virol. 2011, 85(23):12464-12473.
21. Brison E., Jacomy H., Desforges M., Talbot P.J. Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus. J. Virol. 2014, 88(3):1548-1563.
22. Brouard J., Vabret A., Nimal-Cuvillon D., Bach N., Bessiere A., Arion A., Freymuth F. Epidemiology of acute upper and lower respiratory tract infections in children. Rev. Prat. 2007, 57(16):1759-1766.
23. Buchmeier M.J., Lane T.E. Viral-induced neurodegenerative disease. Curr. Opin. Microbiol. 1999, 2(4):398-402.
24. Butler N., Pewe L., Trandem K., Perlman S. Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated. Virology 2006, 347(2):410-421.
25. Cabeca T.K., Granato C., Bellei N. Epidemiological and clinical features of human coronavirus infections among different subsets of patients. Influenza Other Respir. Viruses 2013, 7(6):1040-1047.
26. Cali T., Ottolini D., Brini M. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease. Biofactors 2011, 37(3):228-240.
27. Carmen J., Rothstein J.D., Kerr D.A. Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis. Brain Res. 2009, 1263:143-154.
28. Cavanagh D. The coronavirus surface glycoprotein. The Coronaviridae 1995, 73-113. Plenum Press, New York. S.G. Siddell (Ed.).
29. Cavanagh D. Coronaviruses in poultry and other birds. Avian Pathol. 2005, 34(6):439-448.
30. Cesario T.C. Viruses associated with pneumonia in adults. Clin. Infect. Dis. 2012, 55(1):107-113.
31. Chan G., Nogalski M.T., Stevenson E.V., Yurochko A.D. Human cytomegalovirus induction of a unique signalsome during viral entry into monocytes mediates distinct functional changes: a strategy for viral dissemination. J. Leukoc. Biol. 2012, 92(4):743-752.
32. Cherry J.D. The chronology of the 2002-2003 SARS mini pandemic. Paediatr. Respir. Rev. 2004, 5(4):262-269.
33. Chilvers M.A., McKean M., Rutman A., Myint B.S., Silverman M., O'Callaghan C. The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur. Respir. J. 2001, 18(6):965-970.
34. Chiu S.S., Chan K.H., Chu K.W., Kwan S.W., Guan Y., Poon L.L., Peiris J.S. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis. 2005, 40(12):1721-1729.
35. Coleman C.M., Frieman M.B. Emergence of the Middle East respiratory syndrome coronavirus. PLoS Pathog. 2013, 9(9):e1003595.
36. Collins A.R. In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus. Clin. Diagn. Lab. Immunol. 2002, 9(6):1392-1395.
37. Cowley T.J., Weiss S.R. Murine coronavirus neuropathogenesis: determinants of virulence. J. Neurovirol. 2010, 16(6):427-434.
38. Cristallo A., Gambaro F., Biamonti G., Ferrante P., Battaglia M., Cereda P.M. Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients. N. Microbiol. 1997, 20(2):105-114.
39. Cruz J.L., Sola I., Becares M., Alberca B., Plana J., Enjuanes L., Zuniga S. Coronavirus gene 7 counteracts host defenses and modulates virus virulence. PLoS Pathog. 2011, 7(6):e1002090.
40. Cusick M.F., Libbey J.E., Fujinami R.S. Multiple sclerosis: autoimmunity and viruses. Curr. Opin. Rheumatol. 2013, 25(4):496-501.
41. de Groot R.J. Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses. Glycoconj. J. 2006, 23(1-2):59-72.
42. de Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., Fouchier R.A., Galiano M., Gorbalenya A.E., Memish Z., Perlman S., Poon L.L., Snijder E.J., Stephens G.M., Woo P.C., Zaki A.M., Zambon M., Ziebuhr J. Middle East respiratory syndrome coronavirus (MERS-CoV); announcement of the Coronavirus Study Group. J. Virol. 2013, 87:7790-7792.
43. Dedeurwaerder A., Desmarets L.M., Olyslaegers D.A., Vermeulen B.L., Dewerchin H.L., Nauwynck H.J. The role of accessory proteins in the replication of feline infectious peritonitis virus in peripheral blood monocytes. Vet. Microbiol. 2013, 162(2-4):447-455.
44. DeDiego M.L., Nieto-Torres J.L., Jimenez-Guardeno J.M., Regla-Nava J.A., Alvarez E., Oliveros J.C., Zhao J., Fett C., Perlman S., Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 2011, 7(10):e1002315.
45. Desforges M., Desjardins J., Zhang C., Talbot P.J. The acetyl-esterase activity of the hemagglutinin-esterase protein of human coronavirus OC43 strongly enhances the production of infectious virus. J. Virol. 2013, 87(6):3097-3107.
46. Desforges M., Favreau D.J., Brison E., Desjardins J., Meessen-Pinard M., Jacomy H., Talbot P.J. Human coronaviruses. Respiratory pathogens revisited as infectious neuroinvasive, neurtropic, and neurovirulent agents. Neuroviral Infections. RNA Viruses and Retroviruses 2013, 93-121. CRC Press/Taylor and Francis, Boca Raton. S.K. Singh, D. Ruzek (Eds.).
47. Desforges M., Miletti T.C., Gagnon M., Talbot P.J. Activation of human monocytes after infection by human coronavirus 229E. Virus Res. 2007, 130(1-2):228-240.
48. Dijkman R., Jebbink M.F., Koekkoek S.M., Deijs M., Jonsdottir H.R., Molenkamp R., Ieven M., Goossens H., Thiel V., van der Hoek L. Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J. Virol. 2013, 87(11):6081-6090.
49. Ding Z., Fang L., Jing H., Zeng S., Wang D., Liu L., Zhang H., Luo R., Chen H., Xiao S. Porcine epidemic diarrhea virus (PEDV) nucleocapsid protein antagonizes IFN-beta production by sequestering the interaction between IRF3 and TBK1. J. Virol. 2014.
50. Dominguez S.R., Sims G.E., Wentworth D.E., Halpin R.A., Robinson C.C., Town C.D., Holmes K.V. Genomic analysis of 16 Colorado human NL63 coronaviruses identifies a new genotype, high sequence diversity in the N-terminal domain of the spike gene and evidence of recombination. J. Gen. Virol. 2012, 93(Pt 11):2387-2398.
51. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348(20):1967-1976.
52. Escaffre O., Borisevich V., Rockx B. Pathogenesis of Hendra and Nipah virus infection in humans. J. Infect. Dev. Ctries. 2013, 7(4):308-311.
53. Esper F., Ou Z., Huang Y.T. Human coronaviruses are uncommon in patients with gastrointestinal illness. J. Clin. Virol. 2010, 48(2):131-133.
54. Espinoza J.A., Bohmwald K., Cespedes P.F., Gomez R.S., Riquelme S.A., Cortes C.M., Valenzuela J.A., Sandoval R.A., Pancetti F.C., Bueno S.M., Riedel C.A., Kalergis A.M. Impaired learning resulting from Respiratory Syncytial Virus infection. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(22):9112-9117.
55. Favreau D.J., Desforges M., St-Jean J.R., Talbot P.J. A human coronavirus OC43 variant harboring persistence-associated mutations in the S glycoprotein differentially induces the unfolded protein response in human neurons as compared to wild-type virus. Virology 2009, 395(2):255-267.
56. Favreau D.J., Meessen-Pinard M., Desforges M., Talbot P.J. Human coronavirus-induced neuronal programmed cell death is cyclophilin d dependent and potentially caspase dispensable. J. Virol. 2012, 86(1):81-93.
57. Fazzini E., Fleming J., Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Move. Disord.: Off. J. Move. Disord. Soc. 1992, 7(2):153-158.
58. Foley J.E., Rand C., Leutenegger C. Inflammation and changes in cytokine levels in neurological feline infectious peritonitis. J. Feline Med. Surg. 2003, 5(6):313-322.
59. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G., Peiris M., Lim W., Stohr K., Osterhaus A.D. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003, 423(6937):240.
60. Fredericks D.N., Relman D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 1996, 9(1):18-33.
61. Fuk-Woo Chan J., Chan K.H., Choi G.K., To K.K., Tse H., Cai J.P., Yeung M.L., Cheng V.C., Chen H., Che X.Y., Lau S.K., Woo P.C., Yuen K.Y. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 2013, 207(11):1743-1752.
62. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., Gottlieb E., Green D.R., Hengartner M.O., Kepp O., Knight R.A., Kumar S., Lipton S.A., Lu X., Madeo F., Malorni W., Mehlen P., Nunez G., Peter M.E., Piacentini M., Rubinsztein D.C., Shi Y., Simon H.U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012, 19(1):107-120.
63. Gaunt E.R., Hardie A., Claas E.C., Simmonds P., Templeton K.E. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J. Clin. Microbiol. 2010, 48(8):2940-2947.
64. Gerna G., Campanini G., Rovida F., Percivalle E., Sarasini A., Marchi A., Baldanti F. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J. Med. Virol. 2006, 78(7):938-949.
65. Gerna G., Passarani N., Battaglia M., Rondanelli E.G. Human enteric coronaviruses: antigenic relatedness to human coronavirus OC43 and possible etiologic role in viral gastroenteritis. J. Infect. Dis. 1985, 151(5):796-803.
66. Gilden D.H. Infectious causes of multiple sclerosis. Lancet Neurol. 2005, 4(3):195-202.
67. Giovannoni G., Cutter G.R., Lunemann J., Martin R., Munz C., Sriram S., Steiner I., Hammerschlag M.R., Gaydos C.A. Infectious causes of multiple sclerosis. Lancet Neurol. 2006, 5(10):887-894.
68. Giraudon P., Bernard A. Inflammation in neuroviral diseases. J. Neural Transm. 2010, 117(8):899-906.
69. Gorbalenya A.E., Enjuanes L., Ziebuhr J., Snijder E.J. Nidovirales: evolving the largest RNA virus genome. Virus Res. 2006, 117(1):17-37.
70. Gordon J., Gallia G.L., Del Valle L., Amini S., Khalili K. Human polyomavirus JCV and expression of myelin genes. J. Neurovirol. 2000, 6(Suppl 2):S92L 97.
71. Greig A.S., Mitchell D., Corner A.H., Bannister G.L., Meads E.B., Julian R.J. A hemagglutinating virus producing encephalomyelitis in baby pigs. Can. J. Comp. Med. Vet. Sci. 1962, 26(3):49-56.
72. Gu J., Gong E., Zhang B., Zheng J., Gao Z., Zhong Y., Zou W., Zhan J., Wang S., Xie Z., Zhuang H., Wu B., Zhong H., Shao H., Fang W., Gao D., Pei F., Li X., He Z., Xu D., Shi X., Anderson V.M., Leong A.S. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005, 202(3):415-424.
73. Guan Y., Zheng B.J., He Y.Q., Liu X.L., Zhuang Z.X., Cheung C.L., Luo S.W., Li P.H., Zhang L.J., Guan Y.J., Butt K.M., Wong K.L., Chan K.W., Lim W., Shortridge K.F., Yuen K.Y., Peiris J.S., Poon L.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 2003, 302(5643):276-278.
74. Guo Y., Korteweg C., McNutt M.A., Gu J. Pathogenetic mechanisms of severe acute respiratory syndrome. Virus Res. 2008, 133(1):4-12.
75. Haagmans B.L., Al Dhahiry S.H., Reusken C.B., Raj V.S., Galiano M., Myers R., Godeke G.J., Jonges M., Farag E., Diab A., Ghobashy H., Alhajri F., Al-Thani M., Al-Marri S.A., Al Romaihi H.E., Al Khal A., Bermingham A., Osterhaus A.D., AlHajri M.M., Koopmans M.P. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect. Dis. 2014, 14(2):140-145.
76. Hamre D., Procknow J.J. A new virus isolated from the human respiratory tract. Soc. Exp. Biol. Med. 1966, 121(1):190-193.
77. Hankins D.G., Rosekrans J.A. Overview, prevention, and treatment of rabies. Mayo Clinic 2004, 79(5):671-676.
78. Hill A.B. The environment and disease: association or causation?. Proc. R. Soc. Med. 1965, 58:295-300.
79. Hogue B.G., Machamer C.E. Coronavirus structural proteins and virus assembly. Nidoviruses 2008, 179-200. ASM Press, Washington. S. Perlman, T. Gallagher, E.J. Snijder (Eds.).
80. Hosking M.P., Lane T.E. The pathogenesis of murine coronavirus infection of the central nervous system. Crit. Rev. Immunol. 2010, 30(2):119-130.
81. Hovanec D.L., Flanagan T.D. Detection of antibodies to human coronaviruses 229E and OC43 in the sera of multiple sclerosis patients and normal subjects. Infect. Immun. 1983, 41(1):426-429.
82. Hui D.S., Memish Z.A., Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr. Opin. Pulm. Med. 2014, 20(3):233-241.
83. Iacono K.T., Kazi L., Weiss S.R. Both spike and background genes contribute to murine coronavirus neurovirulence. J. Virol. 2006, 80(14):6834-6843.
84. Ison M.G., Hayden F.G. Viral infections in immunocompromised patients: what's new with respiratory viruses?. Curr Opin Infect Dis 2002, 15(4):355-367.
85. Itzhaki R.F., Wozniak M.A., Appelt D.M., Balin B.J. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol. Aging 2004, 25(5):619-627.
86. Jacomy H., Fragoso G., Almazan G., Mushynski W.E., Talbot P.J. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology 2006, 349(2):335-346.
87. Jacomy H., St-Jean J.R., Brison E., Marceau G., Desforges M., Talbot P.J. Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination. J. Neurovirol. 2010, 16(4):279-293.
88. Jacomy H., Talbot P.J. Vacuolating encephalitis in mice infected by human coronavirus OC43. Virology 2003, 315(1):20-33.
89. Jang H., Boltz D.A., Webster R.G., Smeyne R.J. Viral parkinsonism. Biochim. Biophys. Acta 2009, 1792(7):714-721.
90. Jartti T., Jartti L., Ruuskanen O., Soderlund-Venermo M. New respiratory viral infections. Curr. Opin. Pulm. Med. 2012, 18(3):271-278.
91. Jimenez-Guardeno J.M., Nieto-Torres J.L., DeDiego M.L., Regla-Nava J.A., Fernandez-Delgado R., Castano-Rodriguez C., Enjuanes L. The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis. PLoS Pathog. 2014, 10(8):e1004320.
92. Jurgens H.A., Amancherla K., Johnson R.W. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J. Neurosci. 2012, 32(12):3958-3968.
93. Kaiser W.J., Upton J.W., Mocarski E.S. Viral modulation of programmed necrosis. Curr Opin Virol 2013, 3:296-306.
94. Kakalacheva K., Munz C., Lunemann J.D. Viral triggers of multiple sclerosis. Biochim. Biophys. Acta 2011, 1812(2):132-140.
95. Kaplan J.E., Osame M., Kubota H., Igata A., Nishitani H., Maeda Y., Khabbaz R.F., Janssen R.S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Acquir. Immune Defic. Syndr. 1990, 3(11):1096-1101.
96. Kawashima H., Ioi H., Ushio M., Yamanaka G., Matsumoto S., Nakayama T. Cerebrospinal fluid analysis in children with seizures from respiratory syncytial virus infection. Scand. J. Infect. Dis. 2009, 41(3):228-231.
97. Kazi L., Lissenberg A., Watson R., de Groot R.J., Weiss S.R. Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J. Virol. 2005, 79(24):15064-15073.
98. Kim W.K., Corey S., Alvarez X., Williams K. Monocyte/macrophage traffic in HIV and SIV encephalitis. J. Leukoc. Biol. 2003, 74(5):650-656.
99. Koch R. The Aetiology of Tuberculosis 1942, (translation of Die Aetiologie der Tuberculose (1882)), Dover Publications, New York.
100. Koetzner C.A., Kuo L., Goebel S.J., Dean A.B., Parker M.M., Masters P.S. Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus. J. Virol. 2010, 84(16):8262-8274.
101. Kopecky-Bromberg S.A., Martinez-Sobrido L., Frieman M., Baric R.A., Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007, 81(2):548-557.
102. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003, 348(20):1953-1966.
103. Kuiken T., Riteau B., Fouchier R.A., Rimmelzwaan G.F. Pathogenesis of influenza virus infections: the good, the bad and the ugly. Curr Opin Virol 2012, 2(3):276-286.
104. Kurtzke J.F. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 1993, 6(4):382-427.
105. Lai M.M., Cavanagh D. The molecular biology of coronaviruses. Adv. Virus Res. 1997, 48:1-100.
106. Lampert P.W., Sims J.K., Kniazeff A.J. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol. (Berl.) 1973, 24(1):76-85.
107. Larson H.E., Reed S.E., Tyrrell D.A. Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J. Med. Virol. 1980, 5(3):221-229.
108. Lassnig C., Sanchez C.M., Egerbacher M., Walter I., Majer S., Kolbe T., Pallares P., Enjuanes L., Muller M. Development of a transgenic mouse model susceptible to human coronavirus 229E. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(23):8275-8280.
109. Lau S.K., Lee P., Tsang A.K., Yip C.C., Tse H., Lee R.A., So L.Y., Lau Y.L., Chan K.H., Woo P.C., Yuen K.Y. Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J. Virol. 2011, 85(21):11325-11337.
110. Li F.Q., Xiao H., Tam J.P., Liu D.X. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus. FEBS Lett. 2005, 579(11):2387-2396.
111. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005, 310(5748):676-679.
112. Liu D.X., Yuan Q., Liao Y. Coronavirus envelope protein: a small membrane protein with multiple functions. Cell. Mol. Life Sci.: CMLS 2007, 64(16):2043-2048.
113. Mackay I.M., Arden K.E., Speicher D.J., O'Neil N.T., McErlean P.K., Greer R.M., Nissen M.D., Sloots T.P. Co-circulation of four human coronaviruses (HCoVs) in Queensland children with acute respiratory tract illnesses in 2004. Viruses 2012, 4(4):637-653.
114. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 2004, 10(12 Suppl):S98-S109.
115. Macneughton M.R., Davies H.A. Ribonucleoprotein-like structures from coronavirus particles. J. Gen. Virol. 1978, 39(3):545-549.
116. Mathieu C., Pohl C., Szecsi J., Trajkovic-Bodennec S., Devergnas S., Raoul H., Cosset F.L., Gerlier D., Wild T.F., Horvat B. Nipah virus uses leukocytes for efficient dissemination within a host. J. Virol. 2011, 85(15):7863-7871.
117. Matthews A.E., Weiss S.R., Paterson Y. Murine hepatitis virus--a model for virus-induced CNS demyelination. J. Neurovirol. 2002, 8(2):76-85.
118. Mattson M.P., Haughey N.J., Nath A. Cell death in HIV dementia. Cell Death Differ. 2005, 12(Suppl. 1):893-904.
119. McCray P.B., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D., Meyerholz D.K., Kirby P., Look D.C., Perlman S. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 2007, 81(2):813-821.
120. McGavern D.B., Kang S.S. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 2011, 11(5):318-329.
121. McIntosh K., Becker W.B., Chanock R.M. Growth in suckling-mouse brain of IBV-like viruses from patients with upper respiratory tract disease. Proc. Natl. Acad. Sci. U. S. A. 1967, 58(6):2268-2273.
122. Mesel-Lemoine M., Millet J., Vidalain P.O., Law H., Vabret A., Lorin V., Escriou N., Albert M.L., Nal B., Tangy F. A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes. J. Virol. 2012, 86(14):7577-7587.
123. Millichap J.G., Millichap J.J. Role of viral infections in the etiology of febrile seizures. Pediatr. Neurol. 2006, 35(3):165-172.
124. Millichap J.J., Wainwright M.S. Neurological complications of respiratory syncytial virus infection: case series and review of literature. J. Child Neurol. 2009, 24(12):1499-1503.
125. Mori I., Nishiyama Y., Yokochi T., Kimura Y. Olfactory transmission of neurotropic viruses. J. Neurovirol. 2005, 11(2):129-137.
126. Morichi S., Kawashima H., Ioi H., Yamanaka G., Kashiwagi Y., Hoshika A., Nakayama T., Watanabe Y. Classification of acute encephalopathy in respiratory syncytial virus infection. J. Infect. Chemother. 2011, 17(6):776-781.
127. Mueller S., Wimmer E., Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res. 2005, 111(2):175-193.
128. Munster V.J., Prescott J.B., Bushmaker T., Long D., Rosenke R., Thomas T., Scott D., Fischer E.R., Feldmann H., de Wit E. Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci. Rep. 2012, 2:736.
129. Myint S.H. Human coronavirus infections. The Coronaviridae 1995, 389-401. Plenum Press, New York. S.G. Siddell (Ed.).
130. Narayanan K., Huang C., Makino S. Coronavirus accessory proteins. Nidoviruses 2008, ASM Press, Washington, DC. S. Perlman, T. Gallagher, E.J. Snijder (Eds.).
131. Nath A., Berger J. HIV dementia. Curr. Treat. Options Neurol. 2004, 6(2):139-151.
132. Neal J.W. Flaviviruses are neurotropic, but how do they invade the CNS?. J. Infect. 2014, 69(3):203-215.
133. Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008, 82(15):7264-7275.
134. Neuman B.W., Kiss G., Kunding A.H., Bhella D., Baksh M.F., Connelly S., Droese B., Klaus J.P., Makino S., Sawicki S.G., Siddell S.G., Stamou D.G., Wilson I.A., Kuhn P., Buchmeier M.J. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 2011, 174(1):11-22.
135. Nicholls J.M., Butany J., Poon L.L., Chan K.H., Beh S.L., Poutanen S., Peiris J.S., Wong M. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 2006, 3(2):e27.
136. Nicholson K.G., Wood J.M., Zambon M. Influenza. Lancet 2003, 362(9397):1733-1745.
137. Nieto-Torres J.L., DeDiego M.L., Verdia-Baguena C., Jimenez-Guardeno J.M., Regla-Nava J.A., Fernandez-Delgado R., Castano-Rodriguez C., Alcaraz A., Torres J., Aguilella V.M., Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014, 10(5):e1004077.
138. O'Donnell L.A., Rall G.F. Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin. J. Neuroimmune Pharmacol. 2010, 5(3):443-455.
139. Ozkale Y., Erol I., Ozkale M., Demir S., Alehan F. Acute disseminated encephalomyelitis associated with influenza A H1N1 infection. Pediatr. Neurol. 2012, 47(1):62-64.
140. Peiris J.S., Guan Y., Yuen K.Y. Severe acute respiratory syndrome. Nat. Med. 2004, 10(12 Suppl):S88-S97.
141. Phillips J.J., Chua M.M., Lavi E., Weiss S.R. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J. Virol. 1999, 73(9):7752-7760.
142. Phillips J.J., Chua M.M., Rall G.F., Weiss S.R. Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system. Virology 2002, 301(1):109-120.
143. Public Health Agency of Canada Public Health Notice: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) 2014.
144. Raj V.S., Osterhaus A.D., Fouchier R.A., Haagmans B.L. MERS: emergence of a novel human coronavirus. Curr Opin Virol 2014, 5:58-62.
145. Resta S., Luby J.P., Rosenfeld C.R., Siegel J.D. Isolation and propagation of a human enteric coronavirus. Science 1985, 229(4717):978-981.
146. Reuter J.D., Gomez D.L., Wilson J.H., Van Den Pol A.N. Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain. J. Virol. 2004, 78(3):1473-1487.
147. Rhoades R.E., Tabor-Godwin J.M., Tsueng G., Feuer R. Enterovirus infections of the central nervous system. Virology 2011, 411(2):288-305.
148. Riski H., Hovi T. Coronavirus infections of man associated with diseases other than the common cold. J. Med. Virol. 1980, 6(3):259-265.
149. Risku M., Lappalainen S., Rasanen S., Vesikari T. Detection of human coronaviruses in children with acute gastroenteritis. J. Clin. Virol. 2010, 48(1):27-30.
150. Rottier P.J. Background paper. Coronavirus M and HE: two peculiar glycoproteins. Adv. Exp. Med. Biol. 1990, 276:91-94.
151. Ruch T.R., Machamer C.E. The coronavirus E protein: assembly and beyond. Viruses 2012, 4(3):363-382.
152. Schuh C., Wimmer I., Hametner S., Haider L., Van Dam A.M., Liblau R.S., Smith K.J., Probert L., Binder C.J., Bauer J., Bradl M., Mahad D., Lassmann H. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 2014, 128(2):247-266.
153. Severance E.G., Dickerson F.B., Viscidi R.P., Bossis I., Stallings C.R., Origoni A.E., Sullens A., Yolken R.H. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr. Bull. 2011, 37(1):101-107.
154. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1(8441):1313-1315.
155. Sips G.J., Wilschut J., Smit J.M. Neuroinvasive flavivirus infections. Rev. Med. Virol. 2012, 22(2):69-87.
156. Siu K.L., Chan C.P., Chan C., Zheng B.J., Jin D.Y. Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 gene. J. Gen. Virol. 2009, 90(Pt 9):2107-2113.
157. Sloots T.P., Whiley D.M., Lambert S.B., Nissen M.D. Emerging respiratory agents: new viruses for old diseases?. J. Clin. Virol. 2008, 42(3):233-243.
158. Spiegel M., Schneider K., Weber F., Weidmann M., Hufert F.T. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J. Gen. Virol. 2006, 87(Pt 7):1953-1960.
159. St-Jean J.R., Jacomy H., Desforges M., Vabret A., Freymuth F., Talbot P.J. Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J. Virol. 2004, 78(16):8824-8834.
160. Stensballe L.G., Devasundaram J.K., Simoes E.A. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr. Infect. Dis. J. 2003, 22(2 Suppl):S21-S32.
161. Stewart J.N., Mounir S., Talbot P.J. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 1992, 191(1):502-505.
162. Surjit M., Lal S.K. The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect. Genet. Evol. 2008, 8(4):397-405.
163. Talbot P.J., Arnold D., Antel J.P. Virus-induced autoimmune reactions in the CNS. Curr. Top. Microbiol. Immunol. 2001, 253:247-271.
164. Talbot P.J., Desforges M., Brison E., Jacomy H. Coronaviruses as encephalitis-inducing infectious agents. Non-flavirus Encephalitis 2011, 185-202. In-Tech. S. Tkachev (Ed.).
165. Talbot P.J., Jacomy H., Desforges M. Pathogenesis of human coronaviruses other than severe acute respiratory syndrome coronavirus. Nidoviruses 2008, 313-324. ASM Press, Washington, DC. S. Perlman, T. Gallagher, E.J. Snijder (Eds.).
166. Talbot P.J., Paquette J.S., Ciurli C., Antel J.P., Ouellet F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann. Neurol. 1996, 39(2):233-240.
167. Teoh K.T., Siu Y.L., Chan W.L., Schluter M.A., Liu C.J., Peiris J.S., Bruzzone R., Margolis B., Nal B. The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. Mol. Biol. Cell 2010, 21(22):3838-3852.
168. Theamboonlers A., Samransamruajkit R., Thongme C., Amonsin A., Chongsrisawat V., Poovorawan Y. Human coronavirus infection among children with acute lower respiratory tract infection in Thailand. Intervirology 2007, 50(2):71-77.
169. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel. Med. Infect. Dis. 2008, 6(3):114-124.
170. Tseng C.T., Huang C., Newman P., Wang N., Narayanan K., Watts D.M., Makino S., Packard M.M., Zaki S.R., Chan T.S., Peters C.J. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J. Virol. 2007, 81(3):1162-1173.
171. Tyrrell D.A., Bynoe M.L. Cultivation of a novel type of common-cold virus in organ cultures. Br. Med. J. 1965, 1(5448):1467-1470.
172. Vabret A., Dina J., Brison E., Brouard J., Freymuth F. Human coronaviruses. Pathol.-Biol. 2009, 57(2):149-160.
173. Vabret A., Dina J., Mourez T., Gouarin S., Petitjean J., van der Werf S., Freymuth F. Inter- and intra-variant genetic heterogeneity of human coronavirus OC43 strains in France. J. Gen. Virol. 2006, 87(Pt 11):3349-3353.
174. van den Brand J.M., Haagmans B.L., van Riel D., Osterhaus A.D., Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J. Comp. Pathol. 2014, 151(1):83-112.
175. van der Hoek L., Pyrc K., Jebbink M.F., Vermeulen-Oost W., Berkhout R.J., Wolthers K.C., Wertheim-van Dillen P.M., Kaandorp J., Spaargaren J., Berkhout B. Identification of a new human coronavirus. Nat. Med. 2004, 10(4):368-373.
176. Vareille M., Kieninger E., Edwards M.R., Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 2011, 24(1):210-229.
177. Vijgen L., Keyaerts E., Lemey P., Moes E., Li S., Vandamme A.M., Van Ranst M. Circulation of genetically distinct contemporary human coronavirus OC43 strains. Virology 2005, 337(1):85-92.
178. Wang G.F., Li W., Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr. Opin. Neurol. 2010, 23(3):305-311.
179. Weiss S.R., Leibowitz J.L. Coronavirus pathogenesis. Advances in Virus Research 2011, vol. 81:85-164. Elsevier, Boston.
180. Weissert R. Progressive multifocal leukoencephalopathy. J. Neuroimmunol. 2011, 231(1-2):73-77.
181. Wentworth D.E., Tresnan D.B., Turner B.C., Lerman I.R., Bullis B., Hemmila E.M., Levis R., Shapiro L.H., Holmes K.V. Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo. Virology 2005, 335(2):185-197.
182. Whitley R.J., Gnann J.W. Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002, 359(9305):507-513.
183. Wilson M.R., Ludlow M., Duprex W.P. Human paramyxoviruses and infections of the central nervous system. Neuroviral Infections. RNA Viruses and Retroviruses 2013, 341-372. CRC Press/Taylor and Francis, Boca Raton. S.K.R.D. Singh (Ed.).
184. Wong K.T. Emerging epidemic viral encephalitides with a special focus on henipaviruses. Acta Neuropathol. 2010, 120(3):317-325.
185. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., Wong B.H., Poon R.W., Cai J.J., Luk W.K., Poon L.L., Wong S.S., Guan Y., Peiris J.S., Yuen K.Y. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J. Virol. 2005, 79(2):884-895.
186. Woo P.C., Lau S.K., Yip C.C., Huang Y., Tsoi H.W., Chan K.H., Yuen K.Y. Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J. Virol. 2006, 80(14):7136-7145.
187. Xu H., Yasui O., Tsuruoka H., Kuroda K., Hayashi K., Yamada A., Ishizaki T., Yamada Y., Watanabe T., Hosaka Y. Isolation of type B influenza virus from the blood of children. Clin. Infect. Dis. 1998, 27(3):654-655.
188. Xu J., Zhong S., Liu J., Li L., Li Y., Wu X., Li Z., Deng P., Zhang J., Zhong N., Ding Y., Jiang Y. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis.: Off. Pub. Infect. Dis. Soc. Am. 2005, 41(8):1089-1096.
189. Yang Y., Zhang L., Geng H., Deng Y., Huang B., Guo Y., Zhao Z., Tan W. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 2013, 4(12):951-961.
190. Ye Y., Hauns K., Langland J.O., Jacobs B.L., Hogue B.G. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J. Virol. 2007, 81(6):2554-2563.
191. Yeh E.A., Collins A., Cohen M.E., Duffner P.K., Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics 2004, 113(1 Pt 1):e73-e76.
192. You J., Dove B.K., Enjuanes L., DeDiego M.L., Alvarez E., Howell G., Heinen P., Zambon M., Hiscox J.A. Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Gen. Virol. 2005, 86(Pt 12):3303-3310.
193. Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012, 367(19):1814-1820.
194. Zeng J., Wang G., Kang-Sheng L. Influenza virus and CNS infections. Neuroviral Infections. RNA Viruses and Retroviruses 2013, 325-339. CRC Press/Taylor and Francis, Boca Raton. S.K.R.D. Singh (Ed.).
195. Zhao L., Birdwell L.D., Wu A., Elliott R., Rose K.M., Phillips J.M., Li Y., Grinspan J., Silverman R.H., Weiss S.R. Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus. J. Virol. 2013, 87(15):8408-8418.
196. Zhao L., Jha B.K., Wu A., Elliott R., Ziebuhr J., Gorbalenya A.E., Silverman R.H., Weiss S.R. Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 2012, 11(6):607-616.
197. Zhao L., Rose K.M., Elliott R., Van Rooijen N., Weiss S.R. Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J. Virol. 2011, 85(19):10058-10068.
198. Zlateva K.T., Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr. Infect. Dis. J. 2004, 23(11):1065-1066.
199. Zuniga S., Cruz J.L., Sola I., Mateos-Gomez P.A., Palacio L., Enjuanes L. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J. Virol. 2010, 84(4):2169-2175.
200. Zuniga S., Sola I., Moreno J.L., Sabella P., Plana-Duran J., Enjuanes L. Coronavirus nucleocapsid protein is an RNA chaperone. Virology 2007, 357(2):215-227.